News

A team at the Peter Mac is planning for first-in-human trials in five years, hoping this new therapy will eschew the ...
Olumuyiwa Bamgbade . Value-based healthcare can enable timely and optimal sickle cell arthropathy surgical care; Olumuyiwa Bamgbade, Salem ...
Cartesian's mRNA-based cell therapy offers a novel, outpatient approach for autoimmune diseases. Promising results, but Phase ...
Five NY research centers form Empire State Cellular Therapy Consortium to accelerate cell therapy access for patients.
The gene-editing therapy OTQ923 normalized brain blood flow in 3 sickle cell disease patients, suggesting it may lower stroke ...
Around 2,500 people are living with sickle cell disease in the Bay State, and they are advocating for a bill that would improve quality of life for all those dealing with the disease.
Research led by Naval Medical University's Changzheng Hospital in China reports that an off-the-shelf cell therapy built from ...
The first healthy volunteer has been dosed in a Phase 1 study of Cellarity's novel globin-switching therapy CLY-124 for ...
The hunt for a medical breakthrough has been caught up in the Trump administration's political assault on the university.
Months after announcing an M&A deal with AstraZeneca, EsoBiotec has released the first small slice of data on the cell ...
Gabriella Ngang, of Farmington Hills, is one of three in Michigan to take part in a clinical trial of a new sickle cell ...